Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 4
2013 2
2017 1
2018 1
2019 1
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, Gronwald J, Stawicka M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Haus O, Sibilski R, Bodnar L, Sun P, Narod SA, Lubinski J, Huzarski T; Polish Breast Cancer Consortium. Tomiczek-Szwiec J, et al. Among authors: wisniowski r. Br J Cancer. 2022 Jul;127(1):84-91. doi: 10.1038/s41416-022-01770-1. Epub 2022 Mar 7. Br J Cancer. 2022. PMID: 35256754 Free PMC article.
CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J, Cybulski C, Wokołorczyk D, Oszurek O, Górski B, Debniak T, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dziuba I, Gogacz M, Wiśniowski R, Wandzel P, Banaszkiewicz Z, Kurzawski G, Kładny J, Narod SA, Lubiński J. Suchy J, et al. Among authors: wisniowski r. Int J Cancer. 2010 Jun 15;126(12):3005-9. doi: 10.1002/ijc.25003. Int J Cancer. 2010. PMID: 19876921 Free article.
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
Prajzendanc K, Domagała P, Hybiak J, Ryś J, Huzarski T, Szwiec M, Tomiczek-Szwiec J, Redelbach W, Sejda A, Gronwald J, Kluz T, Wiśniowski R, Cybulski C, Łukomska A, Białkowska K, Sukiennicki G, Kulczycka K, Narod SA, Wojdacz TK, Lubiński J, Jakubowska A. Prajzendanc K, et al. Among authors: wisniowski r. Int J Cancer. 2020 Mar 1;146(5):1293-1298. doi: 10.1002/ijc.32655. Epub 2019 Sep 29. Int J Cancer. 2020. PMID: 31469414 Free article.
BRCA1 mutations and colorectal cancer in Poland.
Suchy J, Cybulski C, Górski B, Huzarski T, Byrski T, Dębniak T, Gronwald J, Jakubowska A, Wokołorczyk D, Kurzawski G, Kładny J, Jawień A, Banaszkiewicz Z, Wiśniowski R, Wandzel P, Starzewski J, Lorenc Z, Korobowicz E, Krokowicz P, Horbacka K, Lubiński J, Narod SA. Suchy J, et al. Among authors: wisniowski r. Fam Cancer. 2010 Dec;9(4):541-4. doi: 10.1007/s10689-010-9378-x. Fam Cancer. 2010. PMID: 20862552
Predictors of survival for breast cancer patients with a BRCA1 mutation.
Narod SA, Huzarski T, Gronwald J, Byrski T, Marczyk E, Cybulski C, Szwiec M, Wisniowski R, Birkenfeld B, Kilar E, Sibilski R, Sun P, Lubinski J. Narod SA, et al. Among authors: wisniowski r. Breast Cancer Res Treat. 2018 Apr;168(2):513-521. doi: 10.1007/s10549-017-4605-x. Epub 2017 Dec 15. Breast Cancer Res Treat. 2018. PMID: 29247441
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER).
Potocki PM, Wiśniowski R, Haus D, Chowaniec Z, Kozaczka M, Kustra M, Samborska-Plewicka M, Szweda M, Starzyczny-Słota D, Michalik M, Słomian G, Lebiedzińska A, Jonak-Olczyk N, Łaszewska-Kraińska N, Adamowicz K, Kolenda P, Drosik-Kwaśniewska A, Szwiec M, Dziura R, Czech J, Dąbrowska M, Nowakowska-Zajdel E, Klank-Sokołowska E, Konopka K, Kwinta Ł, Dobrzańska J, Wysocki PJ. Potocki PM, et al. Among authors: wisniowski r. Cancers (Basel). 2023 Sep 1;15(17):4361. doi: 10.3390/cancers15174361. Cancers (Basel). 2023. PMID: 37686636 Free PMC article.
The risk of gastric cancer in carriers of CHEK2 mutations.
Teodorczyk U, Cybulski C, Wokołorczyk D, Jakubowska A, Starzyńska T, Lawniczak M, Domagała P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wiśniowski R, Narod SA, Lubiński J. Teodorczyk U, et al. Among authors: wisniowski r. Fam Cancer. 2013 Sep;12(3):473-8. doi: 10.1007/s10689-012-9599-2. Fam Cancer. 2013. PMID: 23296741
Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy.
Cybulska-Stopa B, Ługowska I, Wiśniowski R, Domagała-Haduch M, Rajczykowski M, Piejko K, Bar-Letkiewicz I, Suwiński R, Regulski K, Mackiewicz J. Cybulska-Stopa B, et al. Among authors: wisniowski r. Contemp Oncol (Pozn). 2020;24(1):34-41. doi: 10.5114/wo.2020.94728. Epub 2020 Mar 30. Contemp Oncol (Pozn). 2020. PMID: 32514236 Free PMC article.
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.
Huzarski T, Byrski T, Gronwald J, Górski B, Domagala P, Cybulski C, Oszurek O, Szwiec M, Gugala K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Siolek M, Surdyka D, Wisniowski R, Posmyk M, Sun P, Lubinski J, Narod SA. Huzarski T, et al. Among authors: wisniowski r. J Clin Oncol. 2013 Sep 10;31(26):3191-6. doi: 10.1200/JCO.2012.45.3571. Epub 2013 Aug 12. J Clin Oncol. 2013. PMID: 23940229
Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility.
Trubicka J, Grabowska-Kłujszo E, Suchy J, Masojć B, Serrano-Fernandez P, Kurzawski G, Cybulski C, Górski B, Huzarski T, Byrski T, Gronwald J, Złowocka E, Kładny J, Banaszkiewicz Z, Wiśniowski R, Kowalska E, Lubinski J, Scott RJ. Trubicka J, et al. Among authors: wisniowski r. BMC Cancer. 2010 Aug 11;10:420. doi: 10.1186/1471-2407-10-420. BMC Cancer. 2010. PMID: 20701755 Free PMC article.
11 results